NAGASHIMA Satoru | Shitoro Clinic

スポンサーリンク

概要

• NAGASHIMA Satoruの詳細を見る
• 同名の論文著者
• Shitoro Clinicの論文著者

関連著者

• NAGASHIMA Satoru

  Shitoro Clinic

• UEMATSU Toshihiko

  Shitoro Clinic

• HISHIDA Akira

  First Department of Medicine, Hamamatsu University School of Medicine

• Hishida Akira

  First Department Of Medicine Hamamatsu University School Of Medicine

• TAJIMA Naoyuki

  Clinical Pharmacology and Biostatistics Department

• KANAMARU Mitsutaka

  Shitoro Clinic

• Ohashi Naro

  1st Department Of Internal Medicine Hamamatsu University School Of Medicine

• Naganuma Hideo

  Clinical Pharmacology And Biostatistics Department

• TORII Hideki

  Shitoro Clinic

• TAJIMA Masami

  Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd.

• OHASHI Naro

  First Department of Medicine, Hamamatsu University School of Medicine

• TOGAWA Akashi

  First Department of Medicine, Hamamatsu University School of Medicine

• Tajima Masami

  Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.

• Akizawa Tadao

  Showa University School Of Medicine

• Togawa Akashi

  First Department Of Medicine Hamamatsu University School Of Medicine

• Akizawa Tadao

  Showa Univ. School Of Medicine Tokyo Jpn

• UCHIDA Eiji

  Showa University School of Medicine

• HARA Katsutoshi

  Clinical Pharmacology Department, GlaxoSmithKline K.K.

• SUYAMA Kazuaki

  Clinical Research Department, GlaxoSmithKline K.K.

• ITOH Hiroshi

  Biomedical Data Sciences Department, GlaxoSmithKline K.K.

• Suyama Kazuaki

  Clinical Research Department Glaxosmithkline K.k.

• Hara Katsutoshi

  Clinical Pharmacology Department Glaxosmithkline K.k.

• Itoh Hiroshi

  Biomedical Data Sciences Department Glaxosmithkline K.k.

もっと見る 閉じる

著作論文

• Prediction of Pharmacokinetics of Antibiotics in Patients with End-Stage Renal Disease(Biopharmacy)
• Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease
• Influence of ALDH2 Genetic Polymorphisms on Aciclovir Pharmacokinetics following Oral Administration of Valaciclovir in Japanese End-stage Renal Disease Patients
• Pharmacokinetic and Pharmacodynamic Properties of Intravenous Darbepoetin Alfa (KRN321) in Japanese Hemodialysis Patients

スポンサーリンク